ANZGOG's Rare Gynaecological Cancer Study EPOCH

EPOCH is a Phase II open label international clinical trial led by Principal Investigator, Professor Clare Scott AM, which seeks to improve outcomes in women with tubo-ovarian or uterine carcinosarcoma by providing patients with access to a treatment that offers a greater degree of clinical benefit compared to currently available standard chemotherapeutic options. This is a significant opportunity for patients who would otherwise not have access to such treatment options